Related Experiment Video
Updated: May 12, 2026
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Expression of E-cadherin in primary endometrial carcinomas: clinicopathological and immunohistochemical analysis of
M Varras1, E Skafida, T Vasilakaki
1Third Department of Obstetrics and Gynecology, Elena Venizelou General Maternity State Hospital, Athens, Greece. mnvarras@otenet.gr
Introduction:
Decreased expression of E-cadherin has been associated with poorly differentiated endometrial carcinomas and poorer outcomes.
Aim:
The purpose of this study was to examine the distribution of E-cadherin immunohistochemical expression in specimens from primary endometrial carcinomas and its relation to classical clinicopathological prognostic factors.
Materials And Methods:
Surgically-resected tissues of 30 patients with primary endometrial carcinomas were studied. Histological type and grade, depth of myometrial invasion, lymph-vascular space invasion, fallopian tube or ovarian invasion, and the presence of tumoral necrosis were evaluated. Immunohistochemical examination was performed on deparaffinized four-microm-thick sections.
Results:
The mean age of patients was 65 years (+/- 11.41). The 63.54% of carcinomas were moderately/poorly differentiated. No statistical correlation was found between the score or intensity of E-cadherin immunohistochemical staining (strong or moderate positive expression) and the clinicopathological factors tested.
Conclusions:
The association of E-cadherin immunoreactivity with the standard clinicopathological factors seemed to be contradictory. The classical clinicopathological factors remain the most important prognostic parameters.
Related Concept Videos
01:19Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
01:25Structure of Cadherins